S&P 500US$7,674.37+0.43%NASDAQUS$26,180.46+0.43%DOWUS$53,277.01+0.98%DAX€26,115.19-0.08%FTSE 100£10,811.86-0.04%NIKKEI 225JP¥65,528.09-0.74%VIXUS$15.92+5.22%BTCUS$79,105.00+2.46%ETHUS$2,510.49+3.41%

News Archive

Every report the desk has filed, searchable by full text, topic, format, symbol and date range.

Filtering:ENPH

Insider Selling Wave Sweeps High-Multiple Growth and Biotech Names

Snowflake, Rhythm Pharmaceuticals and Krystal Biotech executives lead more than $40 million in disclosed disposals, with Dutch Bros the rare insider buy

A dense cluster of Form 4 filings shows heavy insider distribution across software and biotechnology, led by a $16.8 million Snowflake director sale and roughly $15.5 million of combined Rhythm Pharmaceuticals executive sales, while insider buying was limited to a single Dutch Bros board purchase.

SPECIAL REPORTBEARISH15 Aug 2026

Healthcare & PharmaSNOW RYTM KRYS DAR CRSR+2Read report →

Most covered symbols

GSPC NVDA TNX GOOGL BTC-USD IXIC MU AAPL CL=F TLT AMD BABA COIN CRWV GLD META MSFT NDX 000660.KS MSTR NBIS TSLA RKLB SNDK STOXX STOXX50E AMZN AVGO BRK.B BTC PLTR SMCI WMT XOM N225 BRK.A BZ=F DX-Y.NYB GC=F HOOD

Each chip opens the Research terminal for that symbol, where its archive coverage is listed alongside the fundamentals.